NO20051794D0 - Fremgangsmate for fremstilling av epotilonderivater, og nye mellomprodukter for fremgangsmaten, samt fremgangsmater for fremstilling av slike - Google Patents

Fremgangsmate for fremstilling av epotilonderivater, og nye mellomprodukter for fremgangsmaten, samt fremgangsmater for fremstilling av slike

Info

Publication number
NO20051794D0
NO20051794D0 NO20051794A NO20051794A NO20051794D0 NO 20051794 D0 NO20051794 D0 NO 20051794D0 NO 20051794 A NO20051794 A NO 20051794A NO 20051794 A NO20051794 A NO 20051794A NO 20051794 D0 NO20051794 D0 NO 20051794D0
Authority
NO
Norway
Prior art keywords
preparation
processes
novel intermediates
epothilone derivatives
epothilone
Prior art date
Application number
NO20051794A
Other languages
English (en)
Norwegian (no)
Other versions
NO20051794L (no
Inventor
Olivier Loiseleur
Guido Koch
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9944042&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20051794(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20051794L publication Critical patent/NO20051794L/no
Publication of NO20051794D0 publication Critical patent/NO20051794D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20051794A 2002-09-13 2005-04-12 Fremgangsmate for fremstilling av epotilonderivater, og nye mellomprodukter for fremgangsmaten, samt fremgangsmater for fremstilling av slike NO20051794D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0221312.2A GB0221312D0 (en) 2002-09-13 2002-09-13 Organic compounds
PCT/EP2003/010171 WO2004024735A2 (en) 2002-09-13 2003-09-12 A new process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods of preparing same

Publications (2)

Publication Number Publication Date
NO20051794L NO20051794L (no) 2005-04-12
NO20051794D0 true NO20051794D0 (no) 2005-04-12

Family

ID=9944042

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051794A NO20051794D0 (no) 2002-09-13 2005-04-12 Fremgangsmate for fremstilling av epotilonderivater, og nye mellomprodukter for fremgangsmaten, samt fremgangsmater for fremstilling av slike

Country Status (30)

Country Link
US (1) US7470792B2 (da)
EP (1) EP1539768B1 (da)
JP (1) JP4628102B2 (da)
KR (1) KR20050042500A (da)
CN (1) CN100522968C (da)
AR (1) AR041231A1 (da)
AT (1) ATE373663T1 (da)
AU (2) AU2003267349B2 (da)
BR (1) BR0314263A (da)
CA (1) CA2497119C (da)
CY (1) CY1107794T1 (da)
DE (1) DE60316456T2 (da)
DK (1) DK1539768T3 (da)
EC (1) ECSP055652A (da)
ES (1) ES2290489T3 (da)
GB (1) GB0221312D0 (da)
HK (1) HK1078853A1 (da)
IL (1) IL166829A (da)
MX (1) MXPA05002785A (da)
MY (1) MY140442A (da)
NO (1) NO20051794D0 (da)
NZ (1) NZ538612A (da)
PE (1) PE20050052A1 (da)
PL (1) PL375039A1 (da)
PT (1) PT1539768E (da)
RU (2) RU2343155C2 (da)
SG (1) SG155770A1 (da)
TW (1) TWI289563B (da)
WO (1) WO2004024735A2 (da)
ZA (1) ZA200501008B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
PT1767535E (pt) 2002-08-23 2010-02-24 Sloan Kettering Inst Cancer Síntese de epotilonas, respectivos intermediários, análogos e suas utilizações
CA2799202C (en) 2010-05-18 2016-07-05 Cerulean Pharma Inc. Compositions and methods for treatment of autoimmune and other diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6441186B1 (en) * 1996-12-13 2002-08-27 The Scripps Research Institute Epothilone analogs
US6498257B1 (en) * 1998-04-21 2002-12-24 Bristol-Myers Squibb Company 2,3-olefinic epothilone derivatives
GB9810659D0 (en) * 1998-05-18 1998-07-15 Ciba Geigy Ag Organic compounds
JP2003505459A (ja) * 1999-07-22 2003-02-12 シエーリング アクチエンゲゼルシャフト エポチロンｂおよび誘導体製造のための方法、ならびにこの方法のための中間製品
US6593115B2 (en) * 2000-03-24 2003-07-15 Bristol-Myers Squibb Co. Preparation of epothilone intermediates
US6989450B2 (en) * 2000-10-13 2006-01-24 The University Of Mississippi Synthesis of epothilones and related analogs
EP1524979A2 (en) * 2002-07-31 2005-04-27 Schering AG New effector conjugates, process for their production and their pharmaceutical use

Also Published As

Publication number Publication date
BR0314263A (pt) 2005-07-05
KR20050042500A (ko) 2005-05-09
ES2290489T3 (es) 2008-02-16
WO2004024735A2 (en) 2004-03-25
US20060106073A1 (en) 2006-05-18
MY140442A (en) 2009-12-31
NO20051794L (no) 2005-04-12
MXPA05002785A (es) 2005-06-03
EP1539768A2 (en) 2005-06-15
CY1107794T1 (el) 2013-06-19
AU2003267349A1 (en) 2004-04-30
CA2497119A1 (en) 2004-03-25
ECSP055652A (es) 2005-05-30
PL375039A1 (en) 2005-11-14
DE60316456T2 (de) 2008-06-19
AU2003267349B2 (en) 2008-05-01
US7470792B2 (en) 2008-12-30
JP2006511469A (ja) 2006-04-06
AU2008203451A1 (en) 2008-08-21
HK1078853A1 (en) 2006-03-24
DE60316456D1 (de) 2007-10-31
EP1539768B1 (en) 2007-09-19
CN100522968C (zh) 2009-08-05
TWI289563B (en) 2007-11-11
ATE373663T1 (de) 2007-10-15
SG155770A1 (en) 2009-10-29
GB0221312D0 (en) 2002-10-23
RU2343155C2 (ru) 2009-01-10
DK1539768T3 (da) 2008-01-07
RU2008129613A (ru) 2010-01-27
CA2497119C (en) 2011-08-02
WO2004024735A3 (en) 2004-07-22
IL166829A (en) 2011-01-31
AR041231A1 (es) 2005-05-11
RU2404985C2 (ru) 2010-11-27
PE20050052A1 (es) 2005-03-28
TW200413388A (en) 2004-08-01
JP4628102B2 (ja) 2011-02-09
CN1681824A (zh) 2005-10-12
ZA200501008B (en) 2006-12-27
RU2005110925A (ru) 2006-01-20
PT1539768E (pt) 2007-12-17
NZ538612A (en) 2008-01-31

Similar Documents

Publication Publication Date Title
IL173289A0 (en) Substituted thiazole-benzoisothiazole dioxide derivatives, method for the production thereof and use of the same
HK1062331A1 (en) Magnetic sensor, production process of the magnetic sensor and magnetic array suitable for the production process
NO20043345L (no) Fremgangsmate for fremstilling av hydrokarboner
NO20040933L (no) Nye gamma-sekretaseinhibitorer.
NO20051503D0 (no) Pyrazolopyridiner og fremgangsmater for fremstilling og anvendelse av de samme.
NO20053115D0 (no) Fremgangsmate for fremstilling av 2'-forgrenede nukleosider.
NO20052859D0 (no) Fremgangsmate for fremstilling av resperidon og intermediater derav
NO20043586L (no) Fremgangsmate for fremstilling av organiske forbindelser
NO20060184L (no) Fremgangsmate for fremstilling av ikke-peptid substituerte spirobenzoazepinderivater
NO20043842L (no) Nye krystallformer av atorvastatinhemikalsium og fremgangsmater for fremstilling derav, savel som nye fremgangsmater for fremstilling av atorvastatinhemikalsiumform I, VIII og IX
FR2846964B1 (fr) Procede de fabrication de 1,2-epoxy-3-chloropropane
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
NO20051794D0 (no) Fremgangsmate for fremstilling av epotilonderivater, og nye mellomprodukter for fremgangsmaten, samt fremgangsmater for fremstilling av slike
NO20040911L (no) Beskyttede 3,5-dihydroksy-2,2-dimetylvaleronitriler for syntese av epotiloner og derivater, og fremgangsmate for fremstilling og andvendelse derav.
NO20034597D0 (no) Fremgangsmåte for fremstilling av cantaxantin
NO20062043L (no) Glasstilformingsror og glasstykke og fremgangsmate for innbefatning av samme.
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
HK1081999A1 (en) Microbiological method for the production of 7 alpha-substituted 11 alpha-hydrox-ysteroids
NO20044332L (no) Forbedret fremgangsmate for fremstilling av nevirapine
NO20020308L (no) Fremgangsmåte for fremstilling av epotilon B og derivater derav samt mellomprodukter for fremgangsmåten
IL173447A0 (en) Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same
DK1513833T3 (da) Nye forbindelser af 3-(4-oxo-4H-chromen-2-yl)-(1H)-quinolin-4-on, fremgangsmåde til fremstilling af samme samt farmaceutiske sammensætninger indeholdende samme
ITMI20031670A1 (it) Processo per la preparazione di cilostazolo e di suoi intermedi.
PL373972A1 (en) Process for the preparation of morpholine derivatives and intermediates therefore
AU2003264822A1 (en) Epothilone derivatives for the treatment of multiple myeloma

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application